Many people with type 2 diabetes mellitus (T2DM) fail to achieve glycaemic control promptly
after diagnosis and do not receive timely treatment intensification. This may be in part due to …

Background and aim One of the greatest barriers to the treatment of T2DM is nonadherence
which particularly applies to insulin therapy. There is a need for a comprehensive overview …

Background: This observational study investigated whether the connected NovoPen® 6
could influence insulin regimen management and glycemic control in people with type 1 …

Adherence to antihyperglycemic medications is often suboptimal in patients with type 2
diabetes, and this can contribute to poor glycemic control, increased hospitalization, and the …

Objective. To investigate factors associated with insulin adherence in subjects with type 2
diabetes mellitus (T2D) attending a tertiary care centre in Mexico City. Material and Methods …

Background This study quantified how people with diabetes value the unique features of
connected insulin pens and related mobile apps, and the underlying reasons for preferring …

Diabetes is an increasing public health problem, and insulin is the mainstay for treatment of
type 1 diabetes. In type 2 diabetes treatment, insulin therapy is used after oral or other …

Background Insulin injection technique re-education and diabetes knowledge
empowerment has led to improved glycemic control. Objectives To evaluate the impact of …

The aim of this study was to assess insulin non‐adherence among patients with type 2
diabetes (T2DM) to better understand relationships between adherence, basal insulin (BI) …

Background Diabetes is a threat to peoples' lives around the world, particularly in the Middle
East. Medicine misuse and poor glycaemic control are prevalent among patients with type 2 …